Nomura Intl Equity Compounders (S:0P00003IUR)
23.91
-0.15
(-0.64%)
USD |
Sep 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 29, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| SAP SE | 4.81% | 240.94 | -1.66% |
| Amadeus IT Group SA | 4.72% | 73.92 | -1.54% |
| Securitas AB | 4.51% | 15.75 | 0.00% |
| Smith & Nephew plc | 4.31% | 15.85 | 0.00% |
| ASML Holding NV | 4.30% | 1106.00 | 3.36% |
| Roche Holding AG | 3.99% | 403.76 | -2.78% |
| Accenture Plc | 3.78% | 271.09 | 0.41% |
| Coloplast A/S | 3.68% | 83.70 | 0.00% |
| Sodexo SA | 3.60% | 51.28 | 0.00% |
| Anheuser-Busch InBev NV | 3.57% | 62.93 | -0.92% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |